Skip to main content
Fig. 1 | World Journal of Surgical Oncology

Fig. 1

From: RBM5 inhibits tumorigenesis of gliomas through inhibition of Wnt/β-catenin signaling and induction of apoptosis

Fig. 1

RBM5 was downregulated in gliomas and associated with prognosis of gliomas patients. The expression of RBM5 was detected in 51 gliomas tissues and 3 cell lines by RT-qPCR. Then, the relationship of RBM5 level with survival time was analyzed by Kaplan-Meier method and compared by log-rank test. a RT-qPCR analysis of RBM5 mRNA in tumor tissues. b RT-qPCR analysis of RBM5 mRNA in cell lines U87, U251, and SHG44. c The correlation analysis of RBM5 expression with 5-year survival time in gliomas patients. Data were shown as means ± SD of three independent experiments. *P < 0.05 was considered as statistically significant

Back to article page